Advertisement: Hewitsons mid banner
Barr Ellison Solicitors – commercial property
Advertisement: Wild Knight Vodka
RealVNC mid banner careers
Advertisement: Kao Data Centre mid banner
Advertisement: Howard Group mid banner
Advertisement: S-Tech mid banner 3
Advertisement: Cambridge Network mid banner
Advertisement: RSM
Mid banner advertisement: BDO
Advertisement: EBCam mid banner
Advertisement: TTP
Advertisement: Mogrify mid banner
Advertisement: EY Mid banner
ARM Innovation Hub
Advertisement: Simpsons Creative
Advertisement – Charles Stanley mid banner
14 May, 2014 - 14:30 By News Desk

Highly sensitive cancer diagnostic assay

Tech-opps-logo

A UK company has developed a novel mutation detection technology particularly suited for cancer diagnostic.

The diagnostic assay has significantly increased sensitivity and can reliably detect 10 copies of mutated DNA in a background of 10,000 normal copies. They are seeking companies or research institutions to license this technology, or to test or co-develop it towards new applications.

Closing date: 25/04/2015

 

Ref: 13 GB 403U 3SNM

Add new comment

Newsletter Subscription

Stay informed of the latest news and features